SICKLE CELL DISEASE
Live Outcomes and Biometric Monitoring: Potential Implications For Patient Quality of Life in Sickle Cell Disease
17th Annual Sickle Cell and Thalassaemia Conference (2022)
Areas of interest /
Approaches to QoL assessment & their impact
Biomarkers /
EQ-5D-5L
Published in /
HemaSphere, European Haematology Association
< Back to Sanius content
Loading...